Astera Labs (NASDAQ:ALAB) Updates Q3 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its third quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 1.160-1.210 for the period, compared to the consensus earnings per share estimate of 0.730. The company issued revenue guidance of $540.0 million-$560.0 million, compared to the consensus revenue estimate of $410.3 million.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ALAB shares. UBS Group boosted their price target on shares of Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a report on Monday, June 29th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Stifel Nicolaus increased their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Finally, Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $289.00.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded up $40.62 during mid-day trading on Tuesday, reaching $361.67. The company had a trading volume of 9,883,174 shares, compared to its average volume of 5,557,916. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The stock’s 50 day moving average is $360.26 and its 200-day moving average is $231.18. The stock has a market capitalization of $61.99 billion, a PE ratio of 244.37, a price-to-earnings-growth ratio of 3.61 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts anticipate that Astera Labs will post 1.86 EPS for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 139,951 shares of Astera Labs stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total value of $28,012,592.16. Following the transaction, the chief executive officer directly owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. The trade was a 3.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,676,845 shares of company stock worth $444,928,806. Company insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. State Street Corp grew its stake in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the last quarter. Morgan Stanley grew its position in Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock worth $321,818,000 after acquiring an additional 480,009 shares during the last quarter. Amundi grew its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC increased its holdings in Astera Labs by 9.0% during the 4th quarter. Rafferty Asset Management LLC now owns 1,166,716 shares of the company’s stock valued at $194,095,000 after purchasing an additional 96,241 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD raised its position in Astera Labs by 162.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,164,414 shares of the company’s stock valued at $193,713,000 after purchasing an additional 720,844 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.